Cervical cancer shots less cost-effective with age

(AP) -- An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report.

If you want to include this story in your blog, copy and paste this formatted text: